GATA2 and acute myeloid leukemia: Gata2 has been reported to be aberrantly expressed in 87% of de novo AML cases [31]; our analysis of RNA expression data from AML patients shows a good correlation between EVI1 and GATA2 expression (Pearson correlation (r) of 0.42–0.52; unpublished data).